PierianDx
Business Services · Missouri, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6 Cityplace Dr Ste 550, Creve Coeur, Mis...Phone Number
(314) 628-0035Website
www.pieriandx.comRevenue
$14.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PierianDx
Founded in 2014, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its industry-leading clinical genomics technologies, IVD-ready knowledgebase and reporting solution, and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient's bedside, PierianDx drives the adoption of genomics in clinical care and accelerates the fight against somatic cancer and hereditary diseases. PierianDx is headquartered in Missouri, United States.Explore more
PierianDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PierianDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
PierianDx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if PierianDx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at PierianDx
Check if PierianDx has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when PierianDx launches new products
Funding: Get notified immidiatlly once PierianDx has new funding data
Earning: See what the market has to say on PierianDx recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if PierianDx is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined PierianDx as Masked Content
Find more new buyers
Compare Similar Companies to PierianDx
Compare insights from companies similar to PierianDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PierianDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PierianDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PierianDx.
PierianDx financials insights
Gather financial insights about PierianDx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
2021
Debt
$17.5M
Unspecified
$45M
PierianDx Tech Stack
A closer look at the technologies used by PierianDx
Most Recent Scoops
Funding
Funding
Partnership
Partnership, Clinical Systems
New Hire
Executive Move
PierianDx News & Media
Pierian And P4 Diagnostix Collaborate
ST. LOUIS–(BUSINESS WIRE)–Pierian, a global leader in advanced clinical genomics technology and services, is pleased to announce an exciting partnership... Read More The post Pierian And P4 Diagnostix Collaborate appeared first on citybiz.Pierian® and P4 Diagnostix® Collaborate to Help Physician-Owned Laboratories
ST. LOUIS--(BUSINESS WIRE)-- #ClinicalNGS--Pierian®, a global leader in advanced clinical genomics technology and services, is pleased to announce an exciting partnership with P4 Diagnostix®, a leading-edge network of nationally recognized laboratories. Now physician-owned laboratories (POLs) that specialize in urology, gastroenterology, or women’s health, can add next-generation sequencing (NGS) testing for hereditary cancer to their routine diagnostic practice. Lowering the Barrier for In-HousGenome Medical and Pierian Announce Collaboration to Optimize Genomic Testing Programs
SOUTH SAN FRANCISCO, Calif. & ST. LOUIS--(BUSINESS WIRE)--Genome Medical, the leading telehealth provider of genetic services and genomics-based care, and Pierian, the global leader in advanced clinical genomics technology and services, announced a collaboration designed to streamline and optimize onsite genomics programs for health care organizations and provider groups. The companies’ services, when combined with genomic testing capabilities, create an end-to-end patient and clinician experiePierian and Syapse Collaborate with Health Systems, Leveraging Data to Power Precision Oncology
ST. LOUIS--(BUSINESS WIRE)-- #genomicsinpractice--Pierian®, a global leader in advanced clinical genomics technology and services, announced with Syapse®, a leading real-world evidence company, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Pierian’s leading-edge clinical genomics workflow, and precision medicine services with Syapse’s real-world evidence solutions designed to improve outcomes for patients
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PierianDx
Sign Up For FreeTo access detailed company insights
Founded in 2014, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its industry-leading clinical genomics technologies, IVD-ready knowledgebase and reporting solution, and expertise deliver the most integrated, trusted, and collaborative... Read More
